<?xml version="1.0" encoding="UTF-8"?>
<p id="Par14">Since the emergence of SARS-CoV-2, extensive efforts have been made to characterize the features of this novel coronavirus through genomic sequence studies
 <sup>
  <xref ref-type="bibr" rid="CR1">1</xref>–
  <xref ref-type="bibr" rid="CR3">3</xref>
 </sup> and the evaluation of viral protein structure
 <sup>
  <xref ref-type="bibr" rid="CR9">9</xref>–
  <xref ref-type="bibr" rid="CR11">11</xref>,
  <xref ref-type="bibr" rid="CR27">27</xref>,
  <xref ref-type="bibr" rid="CR28">28</xref>
 </sup>. Coronaviruses, which are a large family of single-stranded enveloped RNA viruses, were not recognized as being highly pathogenic in humans until the outbreak of SARS caused by SARS-CoV in 2002–2003 (refs
 <sup>
  <xref ref-type="bibr" rid="CR29">29</xref>,
  <xref ref-type="bibr" rid="CR30">30</xref>
 </sup>). A decade after the SARS pandemic, an outbreak of MERS was detected in Saudi Arabia, caused by MERS-CoV, another highly pathogenic coronavirus
 <sup>
  <xref ref-type="bibr" rid="CR29">29</xref>
 </sup>. In the ensuing years, extensive studies of SARS and MERS have contributed to our understanding of coronavirus biology. On the basis of phylogenic analyses, both SARS-CoV and MERS-CoV are thought to have originated in bats, which are likely to be a major natural reservoir of coronaviruses
 <sup>
  <xref ref-type="bibr" rid="CR29">29</xref>
 </sup>. A number of genetically diverse coronaviruses that are related to SARS-CoV or MERS-CoV have been discovered in bats worldwide
 <sup>
  <xref ref-type="bibr" rid="CR1">1</xref>,
  <xref ref-type="bibr" rid="CR29">29</xref>,
  <xref ref-type="bibr" rid="CR31">31</xref>
 </sup>. SARS-CoV-2 has been shown to have 79.6% genomic sequence identity with SARS-CoV and 96.0% with the bat coronavirus RaTG13 (refs
 <sup>
  <xref ref-type="bibr" rid="CR1">1</xref>–
  <xref ref-type="bibr" rid="CR3">3</xref>,
  <xref ref-type="bibr" rid="CR8">8</xref>
 </sup>). Given this genomic sequence homology, SARS-CoV-2 is thought to share many biological features with SARS-CoV, suggesting that we can apply, at least in part, our rich knowledge of SARS-CoV biology and pathogenesis to understanding SARS-CoV-2 (refs
 <sup>
  <xref ref-type="bibr" rid="CR4">4</xref>,
  <xref ref-type="bibr" rid="CR29">29</xref>,
  <xref ref-type="bibr" rid="CR30">30</xref>
 </sup>). For example, both SARS-CoV and SARS-CoV-2 use ACE2 as an attachment receptor to enter host cells, whereas MERS-CoV uses dipeptidyl peptidase 4 as the attachment receptor
 <sup>
  <xref ref-type="bibr" rid="CR1">1</xref>,
  <xref ref-type="bibr" rid="CR2">2</xref>,
  <xref ref-type="bibr" rid="CR29">29</xref>,
  <xref ref-type="bibr" rid="CR30">30</xref>
 </sup>.
</p>
